Cargando…

A five-day course of ivermectin may reduce the duration of COVID-19 illness

Detalles Bibliográficos
Autores principales:	Ahmed, Sabeena, Khan, Wasif Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312054/ https://www.ncbi.nlm.nih.gov/pubmed/34325042 http://dx.doi.org/10.1016/j.ijid.2021.07.050

Ejemplares similares

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

The Use of Ivermectin in the Treatment of COVID-19
por: Shukla, Ajay Kumar, et al.
Publicado: (2023)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023)

Duration of Illness at the Time of Disability Certification for Mental Illness and Neurological Disorders
por: Jadhav, Prabhu, et al.
Publicado: (2020)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Poor oral health may prolong COVID-19 illness
por: Gupta, Shipra, et al.
Publicado: (2022)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy
por: Hautala, Timo J., et al.
Publicado: (2017)

Rapid COVID-19 rebound in a severe COVID-19 patient during 20-day course of Paxlovid
por: Wang, Yu, et al.
Publicado: (2022)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Emergence of Multidrug-resistant Strain of Vibrio cholerae O1 in Bangladesh and Reversal of Their Susceptibility to Tetracycline after Two Years
por: Faruque, Abu S.G., et al.
Publicado: (2007)

Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Antenatal corticosteroids may contribute to illness in children in the future
por: Casulari, Luiz Augusto, et al.
Publicado: (2022)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

In Reply–Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
por: Lavie, Carl J.
Publicado: (2021)

The Effect of Ivermectin on Cases of COVID-19()
por: Annie, Frank H., et al.
Publicado: (2022)

Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study
por: Chen, Luyan, et al.
Publicado: (2020)

Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
por: Awan, Usman Ayub, et al.
Publicado: (2021)

Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review - authors' reply’
por: Serafim, Rodrigo B., et al.
Publicado: (2021)

Long sleep duration and frequent day-time naps of the infants can be protective for vigabatrin-induced visual field defects
por: Ekici, Barış, et al.
Publicado: (2012)

Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective observational in Saudi Arabia
por: Alqasim, Eman, et al.
Publicado: (2018)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review’ by Serafim et al.
por: Lipes, Jed, et al.
Publicado: (2021)

Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury
por: Heo, Eunyoung, et al.
Publicado: (2020)

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
por: Popp, Maria, et al.
Publicado: (2022)

Duration of isolation and precautions in immunocompromised patients with COVID-19
por: Taramasso, L., et al.
Publicado: (2021)

Cholera Outbreaks in Iran and Duration Time of Outbreaks
por: Tavana, Ali
Publicado: (2009)

Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management
por: Tan, Li, et al.
Publicado: (2020)

Adenoid cystic carcinoma of Bartholin's gland: Report of a case and review of literature
por: Sisodia, Shantilal M., et al.
Publicado: (2013)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections?
por: Ch’ng, Ewe Seng, et al.
Publicado: (2020)

Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections
por: Mustafa, Mohd Zulkifli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d6et7q6b8e23t4s66hrlmegldv